Actualités - page 2 ABL DIAGNOSTICS

Woippy, the 24th of November 2025 at 08.00 am CET – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce a new partnership with seqWell to develop, validate, license, and commercialize an ... Lire la suite

Woippy, the 20th of November 2025 at 08.00 am CET – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, announce that, together with its regional partner ELTA 90 Medical Science doo, it has been awarded a public ... Lire la suite

Woippy, the 18th of November 2025 at 06.00 pm CET – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce that the company presented four scientific posters last week at the AMP 2025 Congress ... Lire la suite

Woippy, the 14th of November at 8:00 am – ABL Diagnostics (Euronext Paris: ABLD), a French company specializing in advanced molecular diagnostics, announces the signing of an exclusive distribution agreement with Eurobio Scientific (Euronext Growth Paris: ALERS, ... Lire la suite

Woippy, le 14 novembre à 8 heures – ABL Diagnostics (Euronext Paris : ABLD), société française spécialisée dans les technologies de diagnostic moléculaire de précision, annonce la signature d’un accord de distribution exclusive avec Eurobio Scientific (Euronext ... Lire la suite

Woippy, le 07 novembre 2025, ABL Diagnostics (FR001400AHX6 – ABLD), société innovante spécialisée dans la microbiologie et le séquençage de pathogènes, et le CHRU de Nancy annoncent le lancement du projet PREDAVIR : PREvenir le DAnger VIRal, cofinancé par l’Union ... Lire la suite

Woippy, le 5 novembre 2025 à 19h00 ABL Diagnostics (ISIN : FR001400AHX6 – Mnémonique : ABLD) (la "Société") annonce avoir procédé en date du 5 novembre 2025 au titre du contrat de liquidité signé avec Invest Securities et conformément aux dispositions de l’article ... Lire la suite

Woippy, November 4th, 2025 – 6:00 pm CET – ABL Diagnostics (FR001400AHX6 – ABLD), a Euronext-listed leader in molecular diagnostics, announces major milestones in its partnership with VELA Diagnostics (VELA Dx), marking a significant expansion in Europe, Middle ... Lire la suite

Woippy, the 30th of October 2025 at 08.00 am CET – Woippy, France – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, today announced the strengthening of its long-term collaboration with Université Grenoble ... Lire la suite

Woippy (France), le 22 octobre 2025 – 18h00 (CET) ABL Diagnostics SA (la « Société ») informe le public qu’Advanced Biological Laboratories SA (ABL SA), sa société mère, a annoncé aujourd’hui, par voie de communiqué distinct, la signature le 16 octobre 2025 d’un ... Lire la suite